Our data from cultured IPF fibroblasts demonstrate the superiority of active site mTOR inhibitors over rapamycin in suppression of expression of pro-fibrotic matrix regulatory proteins, such as type I collagen, EDA-FN, and SPARC, all of which are targets of TGF-β. Here, FN1 is linked to idiopathic interstitial pneumonia.